Kyle Haynes Insider Profile
4 Followers
Kyle Haynes, Director at OncoSil Medical Ltd, holds 6.65M shares in OncoSil Medical Ltd (Ticker: AU:OSL). Most recently, Kyle Haynes Sold 188,337 shares of OncoSil Medical Ltd on Jan 20, 2012 for an estimated value of AU$6.08K.
Kyle Haynes's Trading History
| OSLOncoSil Medical Ltd | Jan 20, 2012 | Director | Informative Sell | 6.08K | AU$4.29M | |||||||||||||||||||||||||||||||||||||||||||
AU:OSL Insider Shares: 6.65M (685.64%)
| ||||||||||||||||||||||||||||||||||||||||||||||||
You May Also Like
Kyle Haynes insider profile FAQ
What is the percentage of profitable transactions made by Kyle Haynes?
The percentage of profitable transactions made by Kyle Haynes is 33%.
What is the average return per transaction made by Kyle Haynes?
The average return per transaction made by Kyle Haynes is -2.60%.
What stocks does Kyle Haynes hold?
Kyle Haynes holds: AU:OSL stocks.
What was Kyle Haynes’s latest transaction?
Kyle Haynes’s latest transaction was an Informative Sell of AU$6.08K.
What is Kyle Haynes's role in OncoSil Medical Ltd?
Kyle Haynes's role in OncoSil Medical Ltd is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
